Global access of patients with kidney disease to health technologies and medications: findings from the Global Kidney Health Atlas project
Date
2018-02-01Author
Alrukhaimi, MonaHtay, Htay
Ashuntantang, Gloria E
Bello, Aminu K.
braum, branko
gharbiğ, mohammed benghanem
Feehally, John
Harris, David C
Bellorin-Fort, Ezequil
KAZANCIOĞLU, RÜMEYZA
Advisor
Type
Metadata
Show full item recordAbstract
Access to essential medications and health products is critical to effective management of kidney disease. Using data from the ISN Global Kidney Health Atlas multinational cross-sectional survey, global access of patients with kidney disease to essential medications and health products was examined. Overall, 125 countries participated, with 118 countries, composing 91.5% of the world's population, providing data on this domain. Most countries were unable to access eGFR and albuminuria in their primary care settings. Only one-third of low-income countries (LICs) were able to measure serum creatinine and none were able to access eGFR or quantify proteinuria. The ability to monitor diabetes mellitus through serum glucose and glycated hemoglobin measurements was suboptimal. Pathology services were rarely available in tertiary care in LICs (12%) and lower middle-income countries (45%). While acute and chronic hemodialysis services were available in almost all countries, acute and chronic peritoneal dialysis services were rarely available in LICs (18% and 29%, respectively). Kidney transplantation was available in 79% of countries overall and in 12% of LICs. While over one-half of all countries publicly funded RRT and kidney medications with or without copayment, this was less common in LICs and lower middle-income countries. In conclusion, this study demonstrated significant gaps in services for kidney care and funding that were most apparent in LICs and lower middle-income countries.
Subject
Related items
Showing items related by title, author, creator and subject.
-
KDIGO Controversies Conference on onco-nephrology: understanding kidney impairment and solid-organ malignancies, and managing kidney cancer
Porta, Camillo; Bamias, Aristotelis; Danesh, Farhad R.; Dębska-Ślizień, Alicja; Gallieni, Maurizio; Gertz, Morie A.; Kielstein, Jan T.; Tesarova, Petra; Wong, Germaine; Cheung, Michael; Wheeler, David C.; Winkelmayer, Wolfgang C.; Małyszko, Jolanta; Abu-Alfa, Ali K.; Amer, Hatem; Beutel, Gernot; Chapman, Jeremy; Chen, Xiaohong; Chudek, Jerzy; Cosmai, Laura; Danesi, Romano; De Stefano, Filippo; Iseki, Kunitoshi; Jaimes, Edgar A.; Jhaveri, Kenar D.; Jurczyszyn, Artur; Kazancioğlu, Rümeyza; Kitchlu, Abhijat; Kollmannsberger, Christian; Lahoti, Amit; Li, Yang; Macía, Manuel; Matsubara, Takeshi; Mitropoulos, Dionysios; Noiri, Eisei; Perazella, Mark A.; Ronco, Pierre; Rosner, Mitchell H.; Soler Romeo, Maria Jose; Sprangers, Ben; Stadler, Walter M.; Stevens, Paul E.; ladimír Tesař, Tesar; Torres da Costa e Silva, Verônica; Vesole, David H.; Vijayan, Anitha; Viklický, Ondřej; Workeneh, Biruh T.; Yanagita, Motoko; Zakharova, Elena (2020-11-01)© 2020 Kidney Disease:Improving Global Outcomes (KDIGO)The association between kidney disease and cancer is multifaceted and complex. Persons with chronic kidney disease (CKD) have an increased incidence of cancer, and ... -
International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in Eastern and Central Europe
Dębska-Ślizień, Alicja; Bello, Aminu K.; Johnson, David W.; Jha, Vivekanand; Harris, David C.H.; Levin, Adeera; Tonelli, Marcello; Saad, Syed; Zaidi, Deenaz; Osman, Mohamed A.; Ye, Feng; Khan, Maryam; Lunney, Meaghan; Okpechi, Ikechi G.; Turan Kazancioglu, Rümeyza (2021-05-01)© 2021 International Society of NephrologyProvision of adequate kidney care for patients with chronic kidney disease or kidney failure (KF) is costly and requires extensive resources. There is an inequality in the global ... -
Capturing and monitoring global differences in untreated and treated end-stage kidney disease, kidney replacement therapy modality, and outcomes
Pecoits-Filho, Roberto; Okpechi, Ikechi G.; Donner, Jo-Ann; Harris, David C.H.; Aljubori, Harith M.; Bello, Aminu K.; Bellorin-Font, Ezequiel; Caskey, Fergus J.; Collins, Allan; Cueto-Manzano, Alfonso M.; Feehally, John; Goh, Bak Leong; Jager, Kitty J.; Nangaku, Masaomi; Rahman, Muhibur; Sahay, Manisha; Saleh, Abdulkarim; Sola, Laura; Turan Kazancioglu, RÜMEYZA; Walker, Rachael C.; Walker, Robert; Yao, Qiang; Yu, Xueqing; Zhao, Ming-Hui; Johnson, David W. (2020-03-01)A large gap between the number of people with end-stage kidney disease (ESKD) who received kidney replacement therapy (KRT) and those who needed it has been recently identified, and it is estimated that approximately ...